PRISMASOL B22GK4/0
Active substance: MAGNESIUM CHLORIDE, ANHYDROUS DEXTROSE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE
INJECTION · MAGNESIUM CHLORIDE 3.05 g/L, ANHYDROUS DEXTROSE 20 g/L, LACTIC ACID 5.4 g/L, SODIUM CHLORIDE 7.07 g/L, SODIUM BICARBONATE 2.21 g/L, POTASSIUM CHLORIDE .314 g/L
United StatesActive
Marketing holder: Vantive US Healthcare LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MAGNESIUM CHLORIDE · 3.05 g/L
- ANHYDROUS DEXTROSE · 20 g/L
- LACTIC ACID · 5.4 g/L
- SODIUM CHLORIDE · 7.07 g/L
- SODIUM BICARBONATE · 2.21 g/L
- POTASSIUM CHLORIDE · .314 g/L
Registration
- Registration number
- 24571-111
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 24571-111 · Verified 2026-10-09 · open in source